Skip to main content
. Author manuscript; available in PMC: 2006 May 22.
Published in final edited form as: Blood. 2005 Jan 6;105(8):3222–3229. doi: 10.1182/blood-2004-11-4205

Table 1.

Inhibition of BMMC migration induced by SPE-7 IgE, IgE + Ag, or SCF by various pharmacologic inhibitors

Target Inhibitor SPE-7 IgE IgE+Ag SCF
Src PTKs PP2   2 μM   10 μM   0.5 μM
Syk Piceatannol  100 μM  120 μM > 200 μM
ER-27319   20 μM   20 μM > 100 μM
Btk Terreic acid > 20 μM > 20 μM > 20 μM
PI3K Wortmannin   5 nM   40 nM   30 nM
LY294002   7 μM   10 μM > 50 μM
MEK PD98059 > 50 μM > 50 μM > 50 μM
JNK SP600125   30 μM   40 μM   40 μM
p38 SB203380   5 μM   2 μM  20 μM
PKC Ro31-8425   4 μM   8 μM  20 μM
cPKC Goö-6976   2 μM   0.5 μM   2 μM
PKA PKI > 100 nM > 100 nM > 100 nM
KT5720 > 100 nM > 100 nM > 100 nM
Rho-K Y-27632  > 10 μM*  > 10 μM*  > 10 μM*
F-actin Cytochalasin D    0.02 μM    0.02 μM    0.08 μM
Ca2+ EGTA   1 mM   1 mM   2 mM
IgV DNP-lysine   0.4 μM   0.4 μM > 100 μM

BMMCs were preincubated with pharmacologic reagents for 30 minutes before being placed in upper wells at the time of addition of 10 μg/mL SPE-7 IgE or 100 ng/mL SCF to lower wells. For IgE+Ag stimulation, BMMCs were sensitized by overnight incubation with 0.5 μg/mL of 206 IgE. BMMCs washed with buffer were preincubated with inhibitors for 30 minutes before being placed in upper wells at the time of addition of 10 ng/mL DNP-HSA. Concentrations for 50% inhibition (IC50) are indicated.

*

Although BMMCs were insensitive to Y-27632, MC/9 mouse mast cells were sensitive with IC50s of 5 μM to 10 μM for SPE-7-, IgE + Ag-, and SCF-induced migration.